$2.14
0.062.89%
Pre-Market: Jan 10, 9:28 AM EDT
Comments
Loading...
Milestone Pharmaceuticals (NASDAQ:MIST) Stock, Earnings Estimates, EPS, And Revenue
Milestone Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Mar 20
EPS Estimate
$-0.170
Quarterly Revenue Estimate
–
Annual Revenue
(as of Sep 30)
(as of Sep 30)
–
Analyze the earnings history of Milestone Pharmaceuticals using advanced sorting and filters.
Data brought to you by Benzinga APIs
Milestone Pharmaceuticals (MIST) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-12 | $-0.14 | $-0.16 | 12.5 % |
| Q2 | 2024-08-08 | $-0.14 | $-0.19 | 26.3 % |
| Q1 | 2024-05-13 | $-0.21 | $-0.26 | 19.2 % |
| Q4 | 2024-03-21 | $-0.32 | $-0.31 | -3.23 % |
Milestone Pharmaceuticals (MIST) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2023-03-29 | $3.50M | $870.00K | 302.3 % |
| Q2 | 2021-08-11 | $15.00M | $3.00M | 400.0 % |
FAQ
When is Milestone Pharmaceuticals (NASDAQ:MIST) reporting earnings?
Milestone Pharmaceuticals (MIST) is scheduled to report earnings on March 20, 2025. The last reported earnings were for reported on November 12, 2024 for Q3.
What were the latest earnings per share (EPS) for Milestone Pharmaceuticals (NASDAQ:MIST)?
The Actual EPS was $-0.14, which beat the estimate of $-0.16.
What were Milestone Pharmaceuticals’s (NASDAQ:MIST) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.